Hans Ehrencrona
71 – 80 of 84
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2010
-
Mark
How to Handle Genetic Information: A Comparison of Attitudes among Patients and the General Population
(
- Contribution to journal › Article
-
Mark
Association of the Variants CASP8 D302H and CASP10 V410I with Breast and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers.
2010) In Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 19. p.2859-2868(
- Contribution to journal › Article
-
Mark
Establishment of the first World Health Organization International Genetic Reference Panel for quantitation of BCR-ABL mRNA.
(
- Contribution to journal › Article
- 2009
-
Mark
Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers
(
- Contribution to journal › Article
-
Mark
Comparison of imatinib 400 mg and 800 mg daily in the front-line treatment of high-risk, Philadelphia-positive chronic myeloid leukemia: a European LeukemiaNet Study.
(
- Contribution to journal › Article
-
Mark
Clinical and cytogenetic features of a population-based consecutive series of 285 pediatric T-cell acute lymphoblastic leukemias: Rare T-cell receptor gene rearrangements are associated with poor outcome.
(
- Contribution to journal › Article
- 2008
-
Mark
U-2973, a novel B-cell line established from a patient with a mature B-cell leukemia displaying concurrent t(14;18) and MYC translocation to a non-IG gene partner.
(
- Contribution to journal › Article
- 2004
-
Mark
A specific requirement for PDGF-C in palate formation and PDGFR-alpha signaling.
(
- Contribution to journal › Article
- 2002
-
Mark
PDGF-A/PDGF alpha-receptor signaling is required for lung growth and the formation of alveoli but not for early lung branching morphogenesis.
(
- Contribution to journal › Article
- 2000
-
Mark
PDGF-C is a new protease-activated ligand for the PDGF alpha-receptor.
(
- Contribution to journal › Article